ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

Katelyn McCray on LinkedIn: Richard Bowman and His Journey with

ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System

ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT)

As part of Cancer Moonshot, FDA seeks to prohibit menthol cigarettes, flavored cigars - The Cancer Letter

Stock Market News 2022-04-28

Journal of Neurosurgery Publication Demonstrates Distinct

NDA for Diazepam Buccal Film Accepted by FDA for Seizure Cluster Treatment

CLPT - ClearPoint Neuro Inc Stock Price and Quote

Journal of Neurosurgery Publication Demonstrates Distinct

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

ClearPoint Neuro, Inc. on LinkedIn: #clearpoint #nsgy #clpt

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

ClearPoint Navigation System for Drug Delivery

NDA for Diazepam Buccal Film Accepted by FDA for Seizure Cluster Treatment

FDA Clears Neurostimulation Device for Opioid Withdrawal Relief